Boule Diagnostics (Sweden) Buy Hold or Sell Recommendation
| BOUL Stock | SEK 9.70 0.08 0.83% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Boule Diagnostics AB is 'Strong Sell'. Macroaxis provides Boule Diagnostics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BOUL positions. The advice algorithm takes into account all of Boule Diagnostics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Boule Diagnostics' buy or sell advice are summarized below:
Real Value 8.75 | Hype Value 9.7 | Market Value 9.7 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Boule Diagnostics AB given historical horizon and risk tolerance towards Boule Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for Boule Diagnostics AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Boule |
Execute Boule Diagnostics Buy or Sell Advice
The Boule recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Boule Diagnostics AB. Macroaxis does not own or have any residual interests in Boule Diagnostics AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Boule Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Boule Diagnostics Trading Alerts and Improvement Suggestions
| Boule Diagnostics generated a negative expected return over the last 90 days | |
| About 13.0% of the company shares are held by company insiders |
Boule Diagnostics Returns Distribution Density
The distribution of Boule Diagnostics' historical returns is an attempt to chart the uncertainty of Boule Diagnostics' future price movements. The chart of the probability distribution of Boule Diagnostics daily returns describes the distribution of returns around its average expected value. We use Boule Diagnostics AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Boule Diagnostics returns is essential to provide solid investment advice for Boule Diagnostics.
| Mean Return | -0.12 | Value At Risk | -6.19 | Potential Upside | 7.04 | Standard Deviation | 3.17 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Boule Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Boule Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Boule Diagnostics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Boule Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Boule stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.18 | |
β | Beta against NYSE Composite | 0.59 | |
σ | Overall volatility | 2.88 | |
Ir | Information ratio | -0.07 |
Boule Diagnostics Volatility Alert
Boule Diagnostics AB exhibits very low volatility with skewness of 0.23 and kurtosis of 1.62. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Boule Diagnostics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Boule Diagnostics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Boule Diagnostics Fundamentals Vs Peers
Comparing Boule Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Boule Diagnostics' direct or indirect competition across all of the common fundamentals between Boule Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Boule Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Boule Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Boule Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Boule Diagnostics to competition |
| Fundamentals | Boule Diagnostics | Peer Average |
| Return On Equity | 0.0335 | -0.31 |
| Return On Asset | 0.0271 | -0.14 |
| Profit Margin | 0.02 % | (1.27) % |
| Operating Margin | 0.05 % | (5.51) % |
| Current Valuation | 562.26 M | 16.62 B |
| Shares Outstanding | 38.83 M | 571.82 M |
| Shares Owned By Insiders | 12.64 % | 10.09 % |
| Shares Owned By Institutions | 27.69 % | 39.21 % |
| Price To Earning | 24.26 X | 28.72 X |
| Price To Book | 1.06 X | 9.51 X |
| Price To Sales | 0.68 X | 11.42 X |
| Revenue | 463.34 M | 9.43 B |
| Gross Profit | 227.9 M | 27.38 B |
| EBITDA | 55.69 M | 3.9 B |
| Net Income | 23.27 M | 570.98 M |
| Cash And Equivalents | 38.18 M | 2.7 B |
| Cash Per Share | 0.87 X | 5.01 X |
| Total Debt | 50.6 M | 5.32 B |
| Debt To Equity | 46.00 % | 48.70 % |
| Current Ratio | 1.30 X | 2.16 X |
| Book Value Per Share | 11.91 X | 1.93 K |
| Cash Flow From Operations | 43.28 M | 971.22 M |
| Earnings Per Share | 0.96 X | 3.12 X |
| Target Price | 87.0 | |
| Number Of Employees | 200 | 18.84 K |
| Beta | 0.58 | -0.15 |
| Market Capitalization | 532.01 M | 19.03 B |
| Total Asset | 572.03 M | 29.47 B |
| Retained Earnings | (6 M) | 9.33 B |
| Working Capital | 65 M | 1.48 B |
| Current Asset | 135 M | 9.34 B |
| Current Liabilities | 70 M | 7.9 B |
| Z Score | 6.0 | 8.72 |
Boule Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Boule . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Boule Diagnostics Buy or Sell Advice
When is the right time to buy or sell Boule Diagnostics AB? Buying financial instruments such as Boule Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Boule Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Boule Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Boule Stock analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |